BioNTech’s IP team leaders on their role in the race to develop the first covid vaccine

BioNTech’s IP team leaders on their role in the race to develop the first covid vaccine

The long read: In an exclusive interview, the German company's James Ryan and Julie Anne Gillespie talk about their once-in-a-career experience of working on a project that will help change the world

Unlock unlimited access to all IAM content